Back to search
FDAFDA · Food and drugs·Recall number D-0766-2022

Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.

Published April 20, 2022 · Recall initiated: April 5, 2022

Summary

FDA records drug Class III recall D-0766-2022, published April 20, 2022 and initiated April 5, 2022. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 433,809 vials; Lot: Lots: CCC210004, Exp 09/2022; CCC210005, CCC210006, CCC210007, Exp 11/2022; CCC210010, CCC210011, Exp 04/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out of Specification results for Assay

What to do

Voluntary: Firm initiated

Get an email if CYANOCOBALAMIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CYANOCOBALAMIN
Manufacturer
Aurobindo Pharma USA Inc.
Distributor
Nationwide in the USA.
UPC
0355150364015
Lot
Lots: CCC210004, Exp 09/2022; CCC210005, CCC210006, CCC210007, Exp 11/2022; CCC210010, CCC210011, Exp 04/2023.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01. recalled?

Yes. FDA published recall D-0766-2022 on April 20, 2022. Reported hazard: Subpotent Drug: Out of Specification results for Assay

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CYANOCOBALAMIN. UPC: 0355150364015.